 Carolyn Welsh
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis Obliterans | 2 | 2015 | 61 | 0.680 |
Why?
| | Societies, Medical | 2 | 2015 | 899 | 0.450 |
Why?
| | Lung Diseases | 5 | 2024 | 780 | 0.420 |
Why?
| | Lung Transplantation | 1 | 2015 | 332 | 0.340 |
Why?
| | Pulmonary Medicine | 2 | 2014 | 78 | 0.280 |
Why?
| | Hypercapnia | 1 | 2007 | 53 | 0.260 |
Why?
| | Venous Thrombosis | 2 | 2007 | 196 | 0.250 |
Why?
| | Systems Biology | 1 | 2007 | 69 | 0.240 |
Why?
| | Deoxycytidine | 1 | 2007 | 220 | 0.230 |
Why?
| | Endotoxins | 4 | 1993 | 217 | 0.220 |
Why?
| | Syphilis, Cutaneous | 1 | 2004 | 3 | 0.210 |
Why?
| | Treponema pallidum | 1 | 2004 | 10 | 0.210 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 90 | 0.200 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2007 | 302 | 0.190 |
Why?
| | Palliative Care | 2 | 2024 | 1020 | 0.190 |
Why?
| | Pneumonia | 2 | 2007 | 636 | 0.190 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2024 | 195 | 0.170 |
Why?
| | Physician's Role | 1 | 2003 | 223 | 0.160 |
Why?
| | Patient Compliance | 1 | 2024 | 587 | 0.160 |
Why?
| | Patient Care Team | 2 | 2024 | 696 | 0.160 |
Why?
| | Pentoxifylline | 2 | 1991 | 23 | 0.160 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 919 | 0.150 |
Why?
| | Chronic Pain | 1 | 2024 | 291 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2024 | 453 | 0.140 |
Why?
| | Heart Failure | 2 | 2024 | 2326 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 1963 | 0.130 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 664 | 0.120 |
Why?
| | Neutrophils | 4 | 1991 | 1124 | 0.110 |
Why?
| | Prazosin | 1 | 2015 | 25 | 0.110 |
Why?
| | Dreams | 1 | 2015 | 14 | 0.110 |
Why?
| | Capillary Permeability | 4 | 1993 | 132 | 0.110 |
Why?
| | Pneumonia, Mycoplasma | 1 | 1995 | 55 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 961 | 0.100 |
Why?
| | Syndrome | 1 | 2015 | 381 | 0.100 |
Why?
| | Veterans | 2 | 2024 | 1635 | 0.100 |
Why?
| | Pulmonary Ventilation | 1 | 1993 | 82 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1747 | 0.090 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2024 | 890 | 0.090 |
Why?
| | Salmonella enteritidis | 2 | 1989 | 16 | 0.090 |
Why?
| | Pulmonary Embolism | 3 | 1999 | 241 | 0.090 |
Why?
| | Acclimatization | 1 | 1993 | 170 | 0.090 |
Why?
| | Respiratory Insufficiency | 1 | 1995 | 326 | 0.080 |
Why?
| | Antibiotics, Antitubercular | 1 | 1991 | 35 | 0.080 |
Why?
| | Quality of Life | 2 | 2024 | 3204 | 0.080 |
Why?
| | Pulmonary Circulation | 2 | 1993 | 430 | 0.080 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 314 | 0.080 |
Why?
| | Humans | 21 | 2024 | 145474 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1991 | 127 | 0.080 |
Why?
| | Theobromine | 1 | 1988 | 1 | 0.070 |
Why?
| | Gastrectomy | 1 | 1991 | 166 | 0.070 |
Why?
| | Lung | 6 | 1999 | 4106 | 0.070 |
Why?
| | Altitude | 1 | 1993 | 463 | 0.070 |
Why?
| | Pulmonary Artery | 2 | 1993 | 1127 | 0.070 |
Why?
| | Blood Proteins | 2 | 1993 | 239 | 0.070 |
Why?
| | Aging | 1 | 1998 | 1969 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 1991 | 318 | 0.060 |
Why?
| | Diagnosis | 1 | 2007 | 16 | 0.060 |
Why?
| | Aged | 8 | 2024 | 26153 | 0.060 |
Why?
| | Carboplatin | 1 | 2007 | 162 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1581 | 0.060 |
Why?
| | Male | 14 | 2024 | 72842 | 0.060 |
Why?
| | Asthma | 2 | 2014 | 1797 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 3 | 2004 | 2769 | 0.060 |
Why?
| | Single-Blind Method | 2 | 2024 | 318 | 0.060 |
Why?
| | Pulmonary Edema | 3 | 1993 | 105 | 0.060 |
Why?
| | Dyspnea | 1 | 2007 | 250 | 0.060 |
Why?
| | Risk | 1 | 2007 | 919 | 0.050 |
Why?
| | Endothelium, Vascular | 1 | 1991 | 956 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2007 | 258 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2004 | 185 | 0.050 |
Why?
| | Social Workers | 1 | 2024 | 55 | 0.050 |
Why?
| | Comorbidity | 2 | 2024 | 1661 | 0.050 |
Why?
| | Activated Protein C Resistance | 1 | 2003 | 3 | 0.050 |
Why?
| | Medical Laboratory Science | 1 | 2003 | 9 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 2004 | 172 | 0.050 |
Why?
| | Factor V | 1 | 2003 | 26 | 0.050 |
Why?
| | Information Systems | 1 | 2003 | 56 | 0.050 |
Why?
| | Middle Aged | 8 | 2024 | 36215 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2007 | 2930 | 0.050 |
Why?
| | Ossification, Heterotopic | 1 | 2002 | 18 | 0.050 |
Why?
| | Obesity | 2 | 2007 | 3116 | 0.050 |
Why?
| | Nurse's Role | 1 | 2024 | 149 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2015 | 2970 | 0.040 |
Why?
| | Age Distribution | 1 | 2003 | 403 | 0.040 |
Why?
| | Sex Distribution | 1 | 2003 | 387 | 0.040 |
Why?
| | Patient Readmission | 1 | 2007 | 769 | 0.040 |
Why?
| | Certification | 1 | 2003 | 119 | 0.040 |
Why?
| | Adult | 7 | 2024 | 40777 | 0.040 |
Why?
| | Canada | 1 | 2003 | 431 | 0.040 |
Why?
| | Nurses | 1 | 2024 | 171 | 0.040 |
Why?
| | Workload | 1 | 2003 | 168 | 0.040 |
Why?
| | Employment | 1 | 2003 | 184 | 0.040 |
Why?
| | Calcinosis | 1 | 2002 | 234 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1716 | 0.040 |
Why?
| | Needs Assessment | 1 | 2003 | 402 | 0.040 |
Why?
| | Terminal Care | 1 | 2024 | 283 | 0.040 |
Why?
| | Dogs | 3 | 1993 | 458 | 0.040 |
Why?
| | Hypoxia | 1 | 2007 | 1199 | 0.040 |
Why?
| | Snoring | 1 | 1998 | 19 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2024 | 609 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2004 | 5423 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2004 | 713 | 0.040 |
Why?
| | Respiratory Muscles | 1 | 1998 | 37 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 1998 | 43 | 0.040 |
Why?
| | Female | 9 | 2024 | 78844 | 0.040 |
Why?
| | Pulmonary Gas Exchange | 1 | 1998 | 116 | 0.040 |
Why?
| | Respiratory Mechanics | 1 | 1998 | 74 | 0.030 |
Why?
| | Carcinoma, Small Cell | 1 | 1998 | 172 | 0.030 |
Why?
| | Ventilation-Perfusion Ratio | 2 | 1998 | 11 | 0.030 |
Why?
| | Sleep Apnea Syndromes | 1 | 1998 | 98 | 0.030 |
Why?
| | Chronic Disease | 2 | 2019 | 1808 | 0.030 |
Why?
| | United States | 2 | 2024 | 16098 | 0.030 |
Why?
| | Advance Care Planning | 1 | 2019 | 244 | 0.030 |
Why?
| | Tuberculosis | 1 | 1998 | 283 | 0.030 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2015 | 18 | 0.030 |
Why?
| | Depression | 1 | 2024 | 1546 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 1193 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2378 | 0.030 |
Why?
| | Physicians | 1 | 2003 | 955 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1993 | 5 | 0.020 |
Why?
| | Spirometry | 1 | 1993 | 233 | 0.020 |
Why?
| | Vital Capacity | 1 | 1993 | 292 | 0.020 |
Why?
| | Proteins | 2 | 1989 | 1023 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 1993 | 450 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7123 | 0.020 |
Why?
| | Sleep | 1 | 1998 | 888 | 0.020 |
Why?
| | Coronary Vessels | 1 | 1993 | 246 | 0.020 |
Why?
| | Chromium Radioisotopes | 1 | 1991 | 4 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 1991 | 64 | 0.020 |
Why?
| | Permeability | 1 | 1991 | 169 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 852 | 0.020 |
Why?
| | Albumins | 1 | 1991 | 119 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 1991 | 103 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1991 | 207 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 1993 | 343 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2003 | 6066 | 0.020 |
Why?
| | Prognosis | 1 | 1998 | 4316 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 1189 | 0.020 |
Why?
| | Complement C5 | 1 | 1989 | 33 | 0.020 |
Why?
| | Radionuclide Imaging | 2 | 1999 | 115 | 0.020 |
Why?
| | Antitubercular Agents | 1 | 1991 | 208 | 0.020 |
Why?
| | Cattle | 1 | 1991 | 946 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1993 | 1217 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2007 | 2121 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2015 | 11772 | 0.020 |
Why?
| | Neutropenia | 1 | 1988 | 154 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 1991 | 1044 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 144 | 0.020 |
Why?
| | Exercise | 1 | 1998 | 2198 | 0.020 |
Why?
| | Hemodynamics | 2 | 1988 | 1118 | 0.010 |
Why?
| | Blood Pressure | 1 | 1993 | 1779 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 1998 | 2664 | 0.010 |
Why?
| | Animals | 5 | 1993 | 38030 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1374 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1327 | 0.010 |
Why?
| | Tidal Volume | 1 | 2004 | 109 | 0.010 |
Why?
| | Myocardium | 1 | 1988 | 934 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1991 | 4148 | 0.010 |
Why?
| | Blood Coagulation Tests | 1 | 2003 | 72 | 0.010 |
Why?
| | Factor VIII | 1 | 2003 | 106 | 0.010 |
Why?
| | Review Literature as Topic | 1 | 2002 | 52 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1001 | 0.010 |
Why?
| | Sex Factors | 1 | 2007 | 2105 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 499 | 0.010 |
Why?
| | Risk Factors | 2 | 2007 | 10885 | 0.010 |
Why?
| | Kidney | 1 | 1988 | 1497 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 420 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 614 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 3342 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 11853 | 0.010 |
Why?
| | False Negative Reactions | 1 | 1999 | 61 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1998 | 2 | 0.010 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1998 | 6 | 0.010 |
Why?
| | Iohexol | 1 | 1998 | 23 | 0.010 |
Why?
| | Angiography, Digital Subtraction | 1 | 1998 | 48 | 0.010 |
Why?
| | Reference Standards | 1 | 1998 | 177 | 0.010 |
Why?
| | Angiography | 1 | 1998 | 208 | 0.010 |
Why?
| | Probability | 1 | 1998 | 307 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 1998 | 205 | 0.010 |
Why?
| | Critical Illness | 1 | 2004 | 900 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4553 | 0.010 |
Why?
| | Prospective Studies | 2 | 1999 | 8057 | 0.010 |
Why?
| | DNA | 1 | 2003 | 1435 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 1999 | 8333 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 1036 | 0.010 |
Why?
| | Adolescent | 1 | 1995 | 22529 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 2445 | 0.010 |
Why?
| | Ultrasonography | 1 | 1999 | 785 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 497 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3623 | 0.010 |
Why?
| | Child | 1 | 1995 | 22707 | 0.010 |
Why?
| | Oxygenators | 1 | 1993 | 4 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 779 | 0.010 |
Why?
| | Anticoagulants | 1 | 1999 | 748 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 1997 | 0.010 |
Why?
| | Blood Vessels | 1 | 1993 | 167 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1999 | 3413 | 0.010 |
Why?
| | Complement System Proteins | 1 | 1993 | 314 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 5 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 6 | 0.000 |
Why?
| | Thiourea | 1 | 1987 | 41 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 321 | 0.000 |
Why?
| | Lidocaine | 1 | 1987 | 55 | 0.000 |
Why?
| | Organ Size | 1 | 1987 | 461 | 0.000 |
Why?
| | Hydrogen Peroxide | 1 | 1987 | 335 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1987 | 1048 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1999 | 17291 | 0.000 |
Why?
| | Rats | 1 | 1987 | 5584 | 0.000 |
Why?
|
|
Welsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|